L'Oreal says weight loss drugs are impacting beauty and skin care sales

🇫🇷 BBC Business (FR) —
L'Oreal says weight loss drugs are impacting beauty and skin care sales

AI Summary

L'Oréal's chief executive says the growing use of GLP-1 weight-loss drugs is affecting sales in the beauty and skin-care business. The company views the drugs' impact on consumer behavior as a significant phenomenon.

The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us".

Markets Health L'Oréal GLP-1 drugs weight loss beauty industry skin care consumer sales

Read original source →